Drug profile · INN
satralizumab
ENSPRYNG
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
satralizumab (ENSPRYNG) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN satralizumab
Brand ENSPRYNG
Route INJECTION
Formulation INJECTABLE
ATC code L04AC
Frequently asked questions
What is satralizumab?
satralizumab (ENSPRYNG) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for satralizumab?
ENSPRYNG is a marketed brand name for satralizumab. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of satralizumab?
satralizumab has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.